<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font15">for </span>
   <span class="font14">with </span>
   <span class="font13">[]. </span>
   <span class="font13">The </span>
   <span class="font13">patients </span>
   <span class="font12">COVID- </span>
   <span class="font12">treatment </span>
   <span class="font12">was </span>
   <span class="font12">that </span>
   <span class="font12">against </span>
   <span class="font12">are </span>
   <span class="font12">from </span>
   <span class="font11">which </span>
   <span class="font11">can </span>
   <span class="font11">were </span>
   <span class="font11">clinical </span>
   <span class="font11">respiratory </span>
   <span class="font11">use </span>
   <span class="font11">Retrieved </span>
   <span class="font11">been </span>
   <span class="font11">virus </span>
   <span class="font11">has </span>
   <span class="font11">have </span>
   <span class="font11">its </span>
   <span class="font11">coronavirus </span>
   <span class="font11">drug </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">this </span>
   <span class="font11">Apr </span>
   <span class="font11">convalescent </span>
   <span class="font11">disease </span>
   <span class="font11">also </span>
   <span class="font11">antiviral </span>
   <span class="font11">infection </span>
   <span class="font11">their </span>
   <span class="font11">therapy </span>
   <span class="font11">drugs </span>
   <span class="font10">infected </span>
   <span class="font10">viral </span>
   <span class="font10">antibodies </span>
   <span class="font10">not </span>
   <span class="font10">{background </span>
   <span class="font10">than </span>
   <span class="font10">used </span>
   <span class="font10">serum </span>
   <span class="font10">study </span>
   <span class="font10">being </span>
   <span class="font10">effective </span>
   <span class="font10">trials </span>
   <span class="font10">more </span>
   <span class="font10">severe </span>
   <span class="font10">vaccine </span>
   <span class="font10">Dis </span>
   <span class="font10">Infect </span>
   <span class="font10">This </span>
   <span class="font10">but </span>
   <span class="font10">case </span>
   <span class="font10">during </span>
   <span class="font10">other </span>
   <span class="font10">who </span>
   <span class="font10">acute </span>
   <span class="font10">after </span>
   <span class="font10">development </span>
   <span class="font10">margin </span>
   <span class="font10">reported </span>
   <span class="font10">should </span>
   <span class="font10">these </span>
   <span class="font10">{border-style </span>
   <span class="font10">COVID-. </span>
   <span class="font10">However, </span>
   <span class="font10">Med </span>
   <span class="font10">administration </span>
   <span class="font10">antibody </span>
   <span class="font10">caused </span>
   <span class="font10">patients, </span>
   <span class="font10">SARS </span>
   <span class="font10">[], </span>
   <span class="font10">data </span>
   <span class="font10">novel </span>
   <span class="font10">px;} </span>
   <span class="font10">stem </span>
   <span class="font10">studies </span>
   <span class="font10">symptoms </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Ebola </span>
   <span class="font10">dosage </span>
   <span class="font10">human </span>
   <span class="font10">humans </span>
   <span class="font10">observed </span>
   <span class="font10">potential </span>
   <span class="font10">remdesivir </span>
   <span class="font10">syndrome </span>
   <span class="font10">CoVs </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">infections </span>
   <span class="font10">research </span>
   <span class="font10">vaccines </span>
   <span class="font10">chloroquine </span>
   <span class="font10">found </span>
   <span class="font10">initial </span>
   <span class="font10">pneumonia </span>
   <span class="font10">first </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">time </span>
   <span class="font10">blood </span>
   <span class="font10">combination </span>
   <span class="font10">conducted </span>
   <span class="font10">fatality </span>
   <span class="font10">known </span>
   <span class="font10">plasma </span>
   <span class="font10">rate </span>
   <span class="font10">recovered </span>
   <span class="font10">registered </span>
   <span class="font10">such </span>
   <span class="font10">various </span>
   <span class="font10">Chinese </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Not </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">activity </span>
   <span class="font10">associated </span>
   <span class="font10">critically </span>
   <span class="font10">days </span>
   <span class="font10">effect </span>
   <span class="font10">given </span>
   <span class="font10">immune </span>
   <span class="font10">influenza </span>
   <span class="font10">many </span>
   <span class="font10">may </span>
   <span class="font10">patient </span>
   <span class="font10">therapeutic </span>
   <span class="font10">there </span>
   <span class="font10">treated </span>
   <span class="font10">trial </span>
   <span class="font10">when </span>
   <span class="font10">where </span>
   <span class="font10">MERS </span>
   <span class="font10">about </span>
   <span class="font10">any </span>
   <span class="font10">diseases </span>
   <span class="font10">early </span>
   <span class="font10">ill </span>
   <span class="font10">lung </span>
   <span class="font10">monoclonal </span>
   <span class="font10">outbreak </span>
   <span class="font10">passive </span>
   <span class="font10">results </span>
   <span class="font10">tested </span>
   <span class="font10">they </span>
   <span class="font10">through </span>
   <span class="font10">yet </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">agents </span>
   <span class="font10">al. </span>
   <span class="font10">cases </span>
   <span class="font10">cells </span>
   <span class="font10">due </span>
   <span class="font10">efficacy </span>
   <span class="font10">only </span>
   <span class="font10">recent </span>
   <span class="font10">resulted </span>
   <span class="font10">safety </span>
   <span class="font10">those </span>
   <span class="font10">Although </span>
   <span class="font10">East </span>
   <span class="font10">LIF </span>
   <span class="font10">March </span>
   <span class="font10">Middle </span>
   <span class="font10">RNA </span>
   <span class="font10">They </span>
   <span class="font10">administered </span>
   <span class="font10">available </span>
   <span class="font10">cell </span>
   <span class="font10">demonstrated </span>
   <span class="font10">had </span>
   <span class="font10">inhibitor </span>
   <span class="font10">new </span>
   <span class="font10">one </span>
   <span class="font10">phase </span>
   <span class="font10">risk </span>
   <span class="font10">role </span>
   <span class="font10">therapy. </span>
   <span class="font10">under </span>
   <span class="font10">viruses </span>
   <span class="font10">well </span>
   <span class="font10">Health </span>
   <span class="font10">Immunol </span>
   <span class="font10">These </span>
   <span class="font10">both </span>
   <span class="font10">cause </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">cytokine </span>
   <span class="font10">decrease </span>
   <span class="font10">disease. </span>
   <span class="font10">findings </span>
   <span class="font10">four </span>
   <span class="font10">health </span>
   <span class="font10">infectious </span>
   <span class="font10">into </span>
   <span class="font10">investigated </span>
   <span class="font10">levels </span>
   <span class="font10">management </span>
   <span class="font10">might </span>
   <span class="font10">most </span>
   <span class="font10">patients. </span>
   <span class="font10">px; </span>
   <span class="font10">related </span>
   <span class="font10">review </span>
   <span class="font10">sera </span>
   <span class="font10">side </span>
   <span class="font10">spread </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">transmission </span>
   <span class="font10">treat </span>
   <span class="font10">treating </span>
   <span class="font10">values </span>
   <span class="font10">{font-family </span>
   <span class="font10">China </span>
   <span class="font10">Clinical </span>
   <span class="font10">CoV </span>
   <span class="font10">Currently, </span>
   <span class="font10">Engl </span>
   <span class="font10">Mar </span>
   <span class="font10">[â€"]. </span>
   <span class="font10">affected </span>
   <span class="font10">agent </span>
   <span class="font10">all </span>
   <span class="font10">another </span>
   <span class="font10">before </span>
   <span class="font10">between </span>
   <span class="font10">candidate </span>
   <span class="font10">care </span>
   <span class="font10">compared </span>
   <span class="font10">dose </span>
   <span class="font10">factor </span>
   <span class="font10">font-size </span>
   <span class="font10">high </span>
   <span class="font10">infection. </span>
   <span class="font10">interferon </span>
   <span class="font10">led </span>
   <span class="font10">mortality </span>
   <span class="font10">out </span>
   <span class="font10">pandemic </span>
   <span class="font10">published </span>
   <span class="font10">replication </span>
   <span class="font10">response </span>
   <span class="font10">safe </span>
   <span class="font10">secondary </span>
   <span class="font10">several </span>
   <span class="font10">some </span>
   <span class="font10">taken </span>
   <span class="font10">therapies </span>
   <span class="font10">treatments </span>
   <span class="font10">via </span>
   <span class="font10">virus, </span>
   <span class="font10">will </span>
   <span class="font10">would </span>
   <span class="font10">():â€" </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Drug </span>
   <span class="font10">Fig. </span>
   <span class="font10">For </span>
   <span class="font10">Treatment </span>
   <span class="font10">USA </span>
   <span class="font10">Virol </span>
   <span class="font10">action </span>
   <span class="font10">analysis </span>
   <span class="font10">approval </span>
   <span class="font10">approved </span>
   <span class="font10">bacterial </span>
   <span class="font10">characteristics </span>
   <span class="font10">conditions </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">day </span>
   <span class="font10">double; </span>
   <span class="font10">effects </span>
   <span class="font10">global </span>
   <span class="font10">higher </span>
   <span class="font10">immunity </span>
   <span class="font10">including </span>
   <span class="font10">indicating </span>
   <span class="font10">information </span>
   <span class="font10">intensive </span>
   <span class="font10">load </span>
   <span class="font10">made </span>
   <span class="font10">medical </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">need </span>
   <span class="font10">neutralizing </span>
   <span class="font10">oxygen </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">production </span>
   <span class="font10">promising </span>
   <span class="font10">protection </span>
   <span class="font10">receptor </span>
   <span class="font10">reduction </span>
   <span class="font10">ribavirin </span>
   <span class="font10">stages </span>
   <span class="font10">standard </span>
   <span class="font10">still </span>
   <span class="font10">suggested </span>
   <span class="font10">them </span>
   <span class="font10">threat </span>
   <span class="font10">titer </span>
   <span class="font10">treatment. </span>
   <span class="font10">while </span>
   <span class="font10">(Fig.Â </span>
   <span class="font10">Agents </span>
   <span class="font10">Care </span>
   <span class="font10">China, </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Human </span>
   <span class="font10">IL- </span>
   <span class="font10">LIFNano </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">active </span>
   <span class="font10">adverse </span>
   <span class="font10">along </span>
   <span class="font10">although </span>
   <span class="font10">animals </span>
   <span class="font10">anti-COVID- </span>
   <span class="font10">antibodies, </span>
   <span class="font10">bats </span>
   <span class="font10">because </span>
   <span class="font10">beneficial </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">causing </span>
   <span class="font10">clinicians </span>
   <span class="font10">combined </span>
   <span class="font10">controlled </span>
   <span class="font10">countries </span>
   <span class="font10">course </span>
   <span class="font10">days, </span>
   <span class="font10">days. </span>
   <span class="font10">described </span>
   <span class="font10">developing </span>
   <span class="font10">different </span>
   <span class="font10">disease, </span>
   <span class="font10">drug. </span>
   <span class="font10">efficacious </span>
   <span class="font10">elevated </span>
   <span class="font10">employed </span>
   <span class="font10">epidemic </span>
   <span class="font10">even </span>
   <span class="font10">every </span>
   <span class="font10">family </span>
   <span class="font10">following </span>
   <span class="font10">important </span>
   <span class="font10">individuals </span>
   <span class="font10">infection, </span>
   <span class="font10">inhibitors </span>
   <span class="font10">inhibitory </span>
   <span class="font10">lack </span>
   <span class="font10">lopinavir </span>
   <span class="font10">lower </span>
   <span class="font10">major </span>
   <span class="font10">measles </span>
   <span class="font10">medications </span>
   <span class="font10">mice </span>
   <span class="font10">mild </span>
   <span class="font10">model </span>
   <span class="font10">named </span>
   <span class="font10">obtained </span>
   <span class="font10">oral </span>
   <span class="font10">paralysis </span>
   <span class="font10">prevent </span>
   <span class="font10">previously </span>
   <span class="font10">protease </span>
   <span class="font10">recovery </span>
   <span class="font10">release </span>
   <span class="font10">remains </span>
   <span class="font10">scientists </span>
   <span class="font10">screening </span>
   <span class="font10">second </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">stage </span>
   <span class="font10">syncytial </span>
   <span class="font10">therapy, </span>
   <span class="font10">three </span>
   <span class="font10">type </span>
   <span class="font10">working </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Chem </span>
   <span class="font10">Chemother </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Clin </span>
   <span class="font10">FDA </span>
   <span class="font10">Hong </span>
   <span class="font10">Its </span>
   <span class="font10">National </span>
   <span class="font10">Pharmacological </span>
   <span class="font10">Previously, </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">United </span>
   <span class="font10">WHO </span>
   <span class="font10">additional </span>
   <span class="font10">advantages </span>
   <span class="font10">already </span>
   <span class="font10">among </span>
   <span class="font10">amount </span>
   <span class="font10">animal </span>
   <span class="font10">antigen </span>
   <span class="font10">application </span>
   <span class="font10">approach </span>
   <span class="font10">arthritis </span>
   <span class="font10">bold </span>
   <span class="font10">chimeric </span>
   <span class="font10">combating </span>
   <span class="font10">common </span>
   <span class="font10">compassionate </span>
   <span class="font10">concentration </span>
   <span class="font10">concentrations </span>
   <span class="font10">considered </span>
   <span class="font10">conventional </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">currently </span>
   <span class="font10">death </span>
   <span class="font10">develop </span>
   <span class="font10">did </span>
   <span class="font10">distress </span>
   <span class="font10">duration </span>
   <span class="font10">effectiveness </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">evidence </span>
   <span class="font10">examined </span>
   <span class="font10">features </span>
   <span class="font10">fever, </span>
   <span class="font10">followed </span>
   <span class="font10">healthcare </span>
   <span class="font10">hospital </span>
   <span class="font10">host </span>
   <span class="font10">humans, </span>
   <span class="font10">improvement </span>
   <span class="font10">improves </span>
   <span class="font10">infect </span>
   <span class="font10">inflammatory </span>
   <span class="font10">investigation </span>
   <span class="font10">lead </span>
   <span class="font10">less </span>
   <span class="font10">level, </span>
   <span class="font10">light </span>
   <span class="font10">majority </span>
   <span class="font10">million </span>
   <span class="font10">must </span>
   <span class="font10">nitazoxanide </span>
   <span class="font10">now </span>
   <span class="font10">once </span>
   <span class="font10">onset </span>
   <span class="font10">options </span>
   <span class="font10">outcome </span>
   <span class="font10">overall </span>
   <span class="font10">oxide </span>
   <span class="font10">part </span>
   <span class="font10">people </span>
   <span class="font10">period </span>
   <span class="font10">pharmacological </span>
   <span class="font10">plan </span>
   <span class="font10">potent </span>
   <span class="font10">presence </span>
   <span class="font10">produced </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">rates </span>
   <span class="font10">receive </span>
   <span class="font10">receiving </span>
   <span class="font10">recently </span>
   <span class="font10">recommended </span>
   <span class="font10">recuperated </span>
   <span class="font10">regarding </span>
   <span class="font10">required </span>
   <span class="font10">risks </span>
   <span class="font10">severity </span>
   <span class="font10">shed </span>
   <span class="font10">studied </span>
   <span class="font10">study, </span>
   <span class="font10">subjects </span>
   <span class="font10">suffering </span>
   <span class="font10">sufficient </span>
   <span class="font10">suggesting </span>
   <span class="font10">systematic </span>
   <span class="font10">ten </span>
   <span class="font10">testing </span>
   <span class="font10">therapeutics </span>
   <span class="font10">time, </span>
   <span class="font10">treatment, </span>
   <span class="font10">vaccine. </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses, </span>
   <span class="font10">vitro </span>
   <span class="font10">whereas </span>
   <span class="font10">without </span>
   <span class="font10">work </span>
   <span class="font10">â€" </span>
   <span class="font10">â€"Â </span>
  </p>
 </body>
</html>
